Teen girls less successful than boys at quitting meth, pilot study says

April 30, 2013

A UCLA-led study of adolescents receiving treatment for methamphetamine dependence has found that girls are more likely to continue using the drug during treatment than boys, suggesting that new approaches are needed for treating meth abuse among teen girls.

Results from the study, conducted by the UCLA Center for Behavioral and Addiction Medicine and the community-based program Behavioral Health Services Inc., are published in the April edition of the Journal of Adolescent Health.

"The greater severity of methamphetamine problems in compared to boys, combined with results of studies in adults that also found women to be more susceptible to methamphetamine than men, suggests that the in methamphetamine addiction observed in adults may actually begin in adolescence," said the study's lead author, Dr. Keith Heinzerling, a health sciences assistant clinical professor of at the David Geffen School of Medicine at UCLA.

The clinical trial focused on use of the antidepressant bupropion for treating methamphetamine addiction. Nineteen adolescents—nine boys and 10 girls—with meth addiction who were receiving counseling at Behavioral Health Services were given either bupropion or placebo pills. The average age of participants was approximately 17.5 years.

The researchers found that the study subjects who received the antidepressant provided significantly fewer meth-free urine samples than did those who were given placebos, suggesting that bupropion was an ineffective treatment for addiction in this small sample.

Overall, boys in both groups provided more than twice as many meth-free urine drug tests during treatment as girls in both groups.

While the results did not support continued research into the use of bupropion for addiction, they did suggest the need for research to develop new interventions to improve the outcomes of treatment for addiction in adolescent girls, the researchers said.

Heinzerling noted the importance of collaborations such as the one between UCLA and Behavioral Health Services.

"It shows that partnerships between researchers and community organizations are critical to insuring that research is translated into improvements in the health of real people," he said.

Explore further: New study finds that PROMETAT, a controversial methamphetamine treatment program, is ineffective

Related Stories

Meds can help recovering meth addicts stay sober

June 14, 2012

(Medical Xpress) -- A drug shown to help break alcohol addiction can also help recovering methamphetamine addicts stay clean, a study led by University of Virginia School of Medicine researcher Dr. Bankole A. Johnson has ...

First human tests of meth medication completed

December 20, 2012

(Medical Xpress)—InterveXion Therapeutics LLC and the University of Arkansas for Medical Sciences (UAMS) have successfully completed dosing in the first human safety study of a medication to help methamphetamine users fight ...

Recommended for you

Alcoholics may lack key enzyme

September 22, 2016

(HealthDay)—Alcoholics may lack an enzyme that would help them control their impulse to drink, a new study with rats suggests.

Gamblers more prone to violent behavior

September 6, 2016

Men who gamble are more likely to act violently towards others, with the most addicted gamblers the most prone to serious violence, new research has shown.

People with alcohol dependency lack important enzyme

August 30, 2016

A research group under the leadership of Linköping University Professor Markus Heilig has identified an enzyme whose production is turned off in nerve cells of the frontal lobe when alcohol dependence develops. The deficiency ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.